{"nct_id":"NCT06794996","title":"Phase 2b Open-label Study of Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease","status":"RECRUITING","status_verified_date":"2025-01","start_date":"2025-02-04","start_date_type":"ACTUAL","primary_completion_date":"2026-12-30","primary_completion_date_type":"ESTIMATED","completion_date":"2026-12-30","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["VRTX"]}